PHARMACEUTICAL COMPOSITION FOR AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE CONTAINING FK506 BINDING PROTEIN FUSION PROTEIN

摘要

The present invention relates to a pharmaceutical composition for preventing or treating autosomal dominant polycystic kidney disease and, more specifically, to a pharmaceutical composition for preventing or treating autosomal dominant polycystic kidney disease containing FK506 binding protein fusion protein permeable into a polycystic kidney cell.